Emergence of antibiotic resistant Shigella species: A matter of concern

J Infect Public Health. 2018 Jul-Aug;11(4):451-454. doi: 10.1016/j.jiph.2017.09.025. Epub 2017 Oct 20.

Abstract

A major threat to the world is the emergence of antibiotic resistant bacteria, which has rendered previously susceptible drugs useless and increased the rate of therapeutic failures. Shigella species, which are the causative organism of Shigellosis, were earlier susceptible to ampicillin, chloramphenicol, co-trimoxazole and nalidixic acid but now they have developed resistance against fluoroquinolones, cephalosporins and azithromycin. Many shigellosis outbreaks have been reported by resistant strains of Shigella species. This review attempts to provide a brief overview about the scenario of shigellosis and the emergence as well as ubiquitous nature of multidrug resistant (MDR) Shigella species.

Keywords: Antibiotic resistance; Bacteria; Multidrug resistance; Shigellosis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Asia / epidemiology
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial*
  • Dysentery, Bacillary / drug therapy*
  • Dysentery, Bacillary / epidemiology
  • Dysentery, Bacillary / prevention & control
  • Dysentery, Bacillary / transmission
  • Humans
  • Microbial Sensitivity Tests
  • Public Health
  • Shigella / drug effects*

Substances

  • Anti-Bacterial Agents